Acute Exacerbations Treated With BenRAlizumab (The ABRA Study)

NCT04098718 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

158

Enrollment

OTHER

Sponsor class

Conditions

Asthma
COPD

Interventions

DRUG: Benralizumab
DRUG: Prednisolone

Sponsor

University of Oxford